1. Home
  2. BEAT vs PVL Comparison

BEAT vs PVL Comparison

Compare BEAT & PVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAT
  • PVL
  • Stock Information
  • Founded
  • BEAT 2015
  • PVL 2011
  • Country
  • BEAT United States
  • PVL United States
  • Employees
  • BEAT N/A
  • PVL N/A
  • Industry
  • BEAT Retail: Computer Software & Peripheral Equipment
  • PVL Oil & Gas Production
  • Sector
  • BEAT Technology
  • PVL Energy
  • Exchange
  • BEAT Nasdaq
  • PVL Nasdaq
  • Market Cap
  • BEAT 63.5M
  • PVL 57.8M
  • IPO Year
  • BEAT 2021
  • PVL N/A
  • Fundamental
  • Price
  • BEAT $1.56
  • PVL $1.85
  • Analyst Decision
  • BEAT Buy
  • PVL
  • Analyst Count
  • BEAT 1
  • PVL 0
  • Target Price
  • BEAT $8.00
  • PVL N/A
  • AVG Volume (30 Days)
  • BEAT 86.1K
  • PVL 67.8K
  • Earning Date
  • BEAT 11-13-2025
  • PVL 01-01-0001
  • Dividend Yield
  • BEAT N/A
  • PVL 19.46%
  • EPS Growth
  • BEAT N/A
  • PVL N/A
  • EPS
  • BEAT N/A
  • PVL 0.09
  • Revenue
  • BEAT N/A
  • PVL $4,598,992.00
  • Revenue This Year
  • BEAT N/A
  • PVL N/A
  • Revenue Next Year
  • BEAT $28.23
  • PVL N/A
  • P/E Ratio
  • BEAT N/A
  • PVL $19.67
  • Revenue Growth
  • BEAT N/A
  • PVL 37.78
  • 52 Week Low
  • BEAT $0.91
  • PVL $1.30
  • 52 Week High
  • BEAT $3.48
  • PVL $2.04
  • Technical
  • Relative Strength Index (RSI)
  • BEAT 44.23
  • PVL 54.02
  • Support Level
  • BEAT $1.62
  • PVL $1.76
  • Resistance Level
  • BEAT $1.74
  • PVL $1.87
  • Average True Range (ATR)
  • BEAT 0.13
  • PVL 0.05
  • MACD
  • BEAT -0.01
  • PVL 0.00
  • Stochastic Oscillator
  • BEAT 30.88
  • PVL 68.77

About BEAT Heartbeam Inc.

HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

About PVL Permianville Royalty Trust Trust Units

Permianville Royalty Trust is a statutory trust which holds net profits interests in the profits from the sale of oil and natural gas production from non-operated assets of both conventional properties in the States of Texas, Louisiana, and New Mexico as well as unconventional assets in the Permian and Haynesville basins.

Share on Social Networks: